The use of real-time PCR for the diagnosis of Z gene Pi mutation in patients with alpha-1 antitrypsin deficiency
https://doi.org/10.25789/YMJ.2022.78.04
Abstract
The aim of this study is to develop a method for diagnosing PiZ mutation associated with alpha-1 antitrypsin deficiency using real-time PCR technology.
A simple method is proposed for detecting one of the most frequent mutations of the Pi gene PiZ associated with alpha-1 antitrypsin deficiency. Priority exclusion of the PiZ mutation as the most significant one may provide rapid diagnosis and make it more accessible to practical healthcare.
About the Authors
E. V. TapievRussian Federation
Tapiev Evgeny Viktorovich – laboratory geneticist
A. Yu. Asanov
Russian Federation
Asanov Aliy Yuryevich – Doctor of Medical Sciences, Professor of the Department of Medical Genetics
O. I. Simonova
Russian Federation
Simonova Olga Igorevna – Doctor of Medical Sciences, Chief Researcher, Pediatrician
A. L. Sukhomyasova
Russian Federation
Sukhomyasova Aitalina Lukinichna – Candidate of Medical Sciences, Head
K. K. Pavlova
Russian Federation
Pavlova Kunna Konstantinovna – Candidate of Medical Sciences, laboratory geneticist
I. Yu. Chebelyaev
Russian Federation
Chebelyaev Igor Yuryevich – Candidate of Medical Sciences, Associate Professor of the Department of Medical Genetics
References
1. Fundamentals of polymerase chain reaction (PCR), 2019. URL: https://www.dna-technology.ru/sites/default/files/pcr_a5_083-4.pdf
2. Kimberly E. Foil. Variants of SERPINA1 and the increasing complexity of testing for alpha-1 antitrypsin deficiency // Therapeutic Advances in Chronic Disease. 2021, Vol. 12. P. 33–48
3. James K. Stoller, and Loutfi S. Aboussouan. A Review of α1-Antitrypsin Deficiency // American Journal of Respiratory and Critical Care Medicine. 2011. Vol. 185, Issue 3.
4. Cristina M-G, Ignasio B, Isidro D, Patrisia B, Marc M. Estimated Prevalence and Number of PiMZ Genotypes of Alpha-1 Antitrypsin in Seventy-Four Countries Worldwide // International Journal of Chronic Obstructive Pulmonary Disease. 2021 Sep 17. Vol. 16, P. 2617–2630.
5. Kohnlein T, Janciauskiene S, Welte T. Diagnostic delay and clinical modifiers in alpha-1 antitrypsin deficiency // Ther Adv Respir Dis. 2010. Vol 4(5), P. 279–87.
6. Stoller JK, Sandhaus RA, Turino G, Dickson R, Rodgers K, Strange C. Delay in diagnosis of alpha1-antitrypsin deficiency: a continuing problem // Chest. 2005. Vol. 128(4). P. 1898–94.
7. Martina V, et al. Diagnosing Alpha-1-Antitrypsin Deficiency Using A PCR/Luminescence-Based Technology // International Journal of Chronic Obstructive Pulmonary Disease. 2019. Vol. 14. P. 2535–2542.
8. Ilaria F, Stefania O, Annalisa D-S Angelo GC. Update on α1-antitrypsin Deficiency // Breathe. 2018. Vol. 14. P. 17–24.
9. Mark Q, Paul E, Anita P, Alice MT. Obstacles to Early Diagnosis and Treatment of Alpha-1 Antitrypsin Deficiency: Current Perspectives // Therapeutics and Clinical Risk Management. Vol. 16. P. 1243–1255.
10. Timothy J. Craig, Maria Paula Henao. Advances in managing COPD related to α1-antitrypsin deficiency: An under-recognized genetic disorder: // Allergy. 2018. Vol. 73. P. 2110-2121.
Review
For citations:
Tapiev E.V., Asanov A.Yu., Simonova O.I., Sukhomyasova A.L., Pavlova K.K., Chebelyaev I.Yu. The use of real-time PCR for the diagnosis of Z gene Pi mutation in patients with alpha-1 antitrypsin deficiency. Yakut Medical Journal. 2022;(2):16-18. https://doi.org/10.25789/YMJ.2022.78.04